Purchase Order 75N95018P00369
Award Date 6/27/18
Potential Completion Date 9/25/19
Potential Value $83K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $154,713.12 firm fixed price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract is not associated with a set-aside program. Illumina will provide sequencing systems, reagents, and maintenance services to support genomic research and analysis across a range of federal agencies, including the NIH, CDC, USDA, and VA. Illumina has previously been...
- This is a $78,707.44 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract does not have a set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, is providing various sequencing systems, reagents, consumables, and other support services to NIDA under this award. Illumina has previously received...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The $292,500.00 contract is for the provision of Illumina sequencing systems, reagents, and associated products and services to support genomic sequencing and analysis. Illumina is an experienced provider of sequencing and genomic analysis technologies to federal agencies, having previously supported work at the NIH, Centers for...
- This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The $252,500.00 contract is for the provision of Illumina's genetic sequencing systems, reagents, and associated services. This contract does not have a set-aside designation. Illumina is a manufacturer of genetic analysis instruments and reagents, and has previously been awarded both prime federal contracts and...
- The U.S. National Institute on Drug Abuse (NIDA), a civilian agency of the federal government, awarded a firm fixed-price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $8,003.02 contract is for the delivery of a cluster kit and two sequencing kits using Illumina's proprietary technology. This award is not associated with a set-aside program. Illumina has previously secured other prime federal contracts and sub-awards...
- This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $96,908.57 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis research. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Illumina holds with the Department of the Navy Bureau of Medicine and...
- This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and consumables. The $729,384.93 contract supports the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to NIDA. This appears to be a standalone contract award, rather than being associated with a...
- This firm fixed-price delivery order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $323,846.40 award does not have a set-aside designation. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and diagnostics across various federal agencies. This specific delivery...
- This firm fixed-price purchase order for $306,030.00 was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS), to Illumina, Inc. The contract is for the provision of a sequencing instrument required for high-output sequencing gene expression analysis, under the Major Program Code "SEQUENCING INSTRUMENT REQUIRED FOR HIGH-OUTPUT SEQUENCING GENE EXPRESSION ANALYSIS". The award has a completion date of December...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $513,896.40 firm fixed price delivery order contract to Illumina, Inc. to provide sequencing and array-based genomic analysis solutions. Illumina, a for-profit manufacturer, will deliver a range of sequencing systems, reagents, consumables, and bioinformatics products to support the agency's research and diagnostic needs. This order is part of Illumina's existing Indefinite...